Cencora, Inc. (LON:0HF3)
London · Delayed Price · Currency is GBP · Price in USD 290.30
-1.34 (-0.46%)
At close: Aug 14, 2025
Cencora Employees
As of September 30, 2024, Cencora had 46,000 total employees, including 42,000 full-time and 4,000 part-time employees. The number of employees did not change compared to the previous year.
Employees
46,000
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
5.25M GBP
Profits / Employee
31.47K GBP
Market Cap
41.84B
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Sep 30, 2024 | 46,000 | 0 | - |
| Sep 30, 2023 | 46,000 | 2,000 | 4.55% |
| Sep 30, 2022 | 44,000 | 2,000 | 4.76% |
| Sep 30, 2021 | 42,000 | 20,000 | 90.91% |
| Sep 30, 2020 | 22,000 | 0 | - |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| AstraZeneca | 94,300 |
| GSK plc | 68,629 |
| Haleon | 24,561 |
| Smith & Nephew | 17,349 |
| ConvaTec Group | 10,489 |
| Hikma Pharmaceuticals | 9,500 |
| Oxford Nanopore Technologies | 1,382 |
| HUTCHMED (China) | 1,811 |
Cencora News
- 4 days ago - Cencora: Yet Another Strong Quarter, But Valuations Still Aren't Cheap - Seeking Alpha
- 8 days ago - Cencora Q3: Growing Specialty Drug Distributions, Initiate At Buy - Seeking Alpha
- 10 days ago - Cencora, Inc. (COR) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 10 days ago - Cencora raises annual profit forecast on strong demand for specialty drugs - Reuters
- 10 days ago - Cencora Reports Fiscal 2025 Third Quarter Results - Business Wire
- 6 weeks ago - Cencora Announces Date and Time for Third Quarter Fiscal 2025 Earnings Release - Business Wire
- 2 months ago - Cencora Elects Lori J. Ryerkerk to Its Board of Directors - Business Wire
- 3 months ago - Cencora Continues To Deliver As A Healthcare Distributor With Further Growth Signs - Seeking Alpha